The U.S. Food and Drug Administration today expanded the approval of the MiniMed 670 G hybrid closed looped system, a diabetes management device that is intended to automatically monitor glucose and provide appropriate basal insulin doses with little or no input from the user, to include individuals aged 7 to 13 with type 1 diabetes. The FDA origin
Lewes, DE 06/21/2018 Coronary Stents market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. Global Coronary Stents Market: Regional Segment Analysis USA Europe Japan China India South East Asia. The Players mentioned in
Albany, NY 06/21/2018 Intravascular ultrasound is a medical imaging methodology using a specially designed catheter with miniaturized ultrasound probe attached to the distal end. The proximal end of the catheter is attached to computerized ultrasound equipment. It allows application of ultrasonic technology to visualize the blood vessels inte
Albany, NY 06/21/2018 Dialysis refers to the process of cleaning the blood in case of kidney failure or improper functioning of kidneys. There are two types of dialysis; hemodialysis and peritoneal dialysis. Hemodialysis involves pumping out of the blood to an artificial kidney system and is returned back to the body with the help of tubing a
Contract notice: Purchase of medical equipment for the silesian hospital in opava, After- 3rd stage- part 5 peroperative rtg c-arm. The subject of the public contract is the delivery of 1 piece of peroperative RTG Crows+ 5 year post-warranty service within the 3rd phase of the project "Modernization of Equipment for Follow-up Care in the Silesian H
1st Care Home Health Services partnered with the innovative telehealth software company, Health Recovery Solutions, in June 2018. 1st Care Home Health Services has introduced HRS telehealth software to enhance care for patients with congestive heart failure, chronic obstructive pulmonary disease, and severe hypertension. 1st Care Home Health Servic
This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of theGlobal 3D Printing Medical Devices Marketover the forecast period. The 3D print...
According to a new market research report " 3 D Printing Medical Devices Market by Component, Technology, Product Type- Global Forecast to 2022", published by MarketsandMarkets?, the global market is expected to reach USD 1.88 Billion by 2022 from USD 0.84 Billion in 2017, at CAGR of 17.5% from 2017 to 2022.. Browse 78 Market Data Tables and 31 F
The American Association of Nurse Practitioners issued the following news release:. The American Association of Nurse Practitioners, in partnership with more than 70 health care organizations representing NPs, nurses, physicians, hospitals, insurers, drug and device manufacturers, distributors, pharmacies, employers and patients, released today...
BURLINGAME, Calif. and NEW YORK, June 21, 2018/ PRNewswire/ Ablexis LLC, and Deerfield Management announce today the acquisition of Ablexis by Deerfield Management. This acquisition creates a long-term partnership that will enable Ablexis to expand industry access to its AlivaMab Mouse technology, the company's innovative, next-generation transge
"Active Pharmaceutical Ingredients Market" The report titled Global Active Pharmaceutical Ingredients Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover market size, growth rate, opportunities, market Dynamics and Factor Analysis. And also cover the other information such as Active Pharmaceutical
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today an expansion of its relationship with Corium International, Inc. to include the Company s long-acting transdermal patch, AQS1303, for the treatment of nausea and vomiting in pregnancy.
DURHAM- Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced the appointment of William Coppola as Intellectual Property Counsel, reporting to John
June 21 The three unions representing workers at Lawrence+ Memorial Hospital announced they had ratified three-year contracts with the hospital Wednesday, a year before their current contracts expire. The announcement Wednesday came almost two weeks after the nurses' union at the William W. Backus Hospital in Norwich ratified a two-year contract
Agios Pharmaceuticals, Inc. AGIO, announced the initiation of the phase III ACTIVATE study which will evaluateits lead rare genetic diseases candidate, AG-348 in patients with Pyruvate kinase deficiency who do not receive regular blood transfusions. The ACTIVATE study will enroll about 80 adult patients with PK deficiency who do not receive regular
CAMBRIDGE- Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the initiation of the Phase 3 ACTIVATE trial evaluating AG-348, a first-in-class, selective, small molecule activator of the pyruvate kinase-R enzyme. ACTIVATE is a randomized, placebo-controlled trial that
AIVITA Biomedical, a biotech company specializing in innovative stem cell applications, announced today the U.S. Food and Drug Administration has cleared its Investigational New Drug application for a Phase II clinical trial investigating the Company`s ROOT OF CANCER technology in patients with glioblastoma multiforme. This will be the third...
Alexion Pharmaceuticals said that it has submitted a biologics license application to the US Food and Drug Administration, seeking approval for its C5 complement inhibitor ALXN1210 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Alexion executive vice president and research& development head John Orloff said: This first...
The Alzheimer's Association and its advocacy arm, the Alzheimer's Impact Movement, honored U.S. Senators Susan Collins and Catherine Cortez Masto for their significant policy contributions in the fight against Alzheimer's disease. "On behalf of the more than the 28,000 people in Maine and the more than 5 million across America living with Alzheime
Pune, India 06/21/2018 The Global Ambulatory Services Market is a continuously growing market and will grow at similar rate in coming future. The global ambulatory services market is expected to reach USD 3365.2 billion by 2022 from USD 2345.7 billion in 2016 with a CAGR of 5.1% for the forecasted period. Ambulatory services provides convenie
Amgens Blincyto has been granted a full European licence in a form of blood cancer following data showing the drug almost doubled overall survival time compared with standard therapy. The company said the European Commission granted the marketing authorisation based on overall survival data from the phase 3 TOWER study, in adults with Philadelphia.
Aminex Therapeutics, Inc., a clinical-stage drug development company focused on advancing a novel cancer immunotherapy, today announced it received clearance from the Food and Drug Administration to initiate the first Phase 1 clinical trial of its immuno-oncology drug candidate AMXT 1501, a small molecule polyamine uptake inhibitor, and the approve
Its turned out to be a challenging 2018 for Anika Therapeutics new CEO Joseph Darlingand a failed phase 3 trial for lead pipeline drug Cingal wont make his job any easier. While Anika has a positive pivotal trial comparing Cingal with placebo already in hand, the latest miss means it will have to start negotiating with the FDA to see whether combin
Houston, TX 06/21/2018 Research N Reports has announced the addition of a new market intelligence report. Targeted pharmaceuticals for the global market have reached$ 89 billion in 2017. The global anticancer market is showing significant growth and is expected to grow at a significant CAGR over the period from 2018 to 2021. Some of the key p
Appili Therapeutics Inc., a biopharmaceutical company focused on anti-infective drug development, announced today that it will present at the 2018 Atlantic Venture Forum Technology Showcase. The event takes place June 28-29, 2018 in Halifax, Canada. Presentation details are as follows: Date: Thursday, June 28, 2018 Time: 2 p.m. Atlantic time Sessio